INTRODUCTION AND OBJECTIVES: Randall
0 s plaque (RP) is the origin of renal calcification on which idiopathic calcium oxalate (CaOx) and calcium phosphate (CaP) kidney stones develop. We reported the gene expression profile of RP in CaOx stone patients, revealing that renal cell injury, oxidative stress, and ion transporters contribute to RP development. Since prior studies indicated the difference in lithogenesis between CaOx and CaP stones, a detailed investigation of RP with CaP stone is essential to better understand CaP stone formation. Hence, we compared the gene expression profiles in papilla tissue between CaP and CaOx stone patients to elucidate the lithogenesis of RP on CaP stone.
METHODS: Based on our IRB approval, we obtained renal papilla biopsy tissues from 23 idiopathic CaOx and 7 CaP stone patients who had undergone PCNL or URS. Samples were individually collected from two regions in each patient: papillary mucosa with RP (P group) and normal papillary mucosa (N group). We also collected normal renal papillary mucosa as a control group from 7 patients without kidney stones undergoing ureteroscopy for screening. After RNA extraction, we performed a microarray analysis to compare their gene expression patterns. Moreover, causal pathway analysis comparing their differences was performed through the Ingenuity Pathway Analysis (IPA).
RESULTS: No differences in patient clinical backgrounds between CaP, CaOx, and control groups were seen. Cluster analysis demonstrated that gene expression profiles of CaP stone patients (both N and P groups) markedly differed from those of CaOx stone patients (both N and P groups) and non-stone patients (C group). Disease and Function analysis by IPA demonstrated that RP tissues from CaP stone patients had significantly greater cell movements of granulocytes, neutrophils, or T lymphocytes and more activated chemotaxis of phagocytes and leukocytes than those from CaOx stone patients (Table  1) . Additionally, pathway analysis showed developed and activated immune cells via a variety of interleukin, cytokines, and CD antibodies in CaP papilla tissues compared to control normal papillae.
CONCLUSIONS: Our results provide compelling evidence that pro-inflammatory and immune-active responses may lead to RP formation on CaP stone.
Source of Funding: none

MP24-08
IDENTIFICATION OF A NOVEL GENOMIC MUTATIONS THROUGH A NEXT-GENERATION SEQUENCE AMONG JAPANESE CYSTINURIA PATIENTS Shinichi Sakamoto*, Chiba, Japan; Akinori Takei, Asahi, Japan; Takaaki Tamura, Chiba, Japan; Masaaki Fujimura, Narashino, Japan; Hitoshi Yano, Sakura, Japan; Koji Kawamura, Takashi Imamoto, Akira Komiya, Chiba, Japan; Koichiro Akakura, Shinjuku, Japan; Tomohiko Ichikawa, Chiba, Japan INTRODUCTION AND OBJECTIVES: Cystinuria is an autosomal recessive disease, caused by the two mutations in BAT1(SLC7A9)/rBAT(SLC3A1). Around 70% of Japanese Cystinuria patients possessed a characteristics mutation: P482L, which has not been found in European countries. Based on this unique genomic properties, some Japnese patients failed to fit into the genomic classification(two mutations in BAT1(B) or rBAT(A): one mutation in rBAT and BAT1(AB)). Here we studied the genomic profile of the fifty-one Japanese Cystinuria patients.
METHODS: A next-generation sequence was performed among fifty-one patients who previously performed a direct sequence of SLC3A1/SCL7A9, including four patients without any mutation found previously and thirteen unclassifiable patients who possessed only a single mutation. Nextseq 500 was used for the sequencing. The result between previous direct sequence and a next-generation sequence were compared.
RESULTS: The median Cystine concentration was 217.4mM. Overall, 8 novel mutations were identified, includes 2 frameshift(fs) and 5 point mutations and one exon-intron boundary mutation. In SCL7A9, P482L homozygote and heterozygote were found in 16(31.4%) and 17(33.3%) of patients, respectively. Second common mutations were A354T, T69 stop and V340fs found in 2 patients. In SLC3A1, V183A was the most common mutations, found only in 2 patients. In terms of genotype classification, the number of type A, B and AB patients was 5, e292 THE JOURNAL OF UROLOGY â Vol. 199, No. 4S, Supplement, Friday, May 18, 2018 34 and 2, respectively. Compare to direct sequence, 9 patients were reclassified into the novel genotype. However, overall 19.6% of patients still not fit into an autosomal recessive inheritance, with 2 patients possessed no mutation. CONCLUSIONS: Among 51 patients, 8 novel mutations were identified and 9 patients were reclassified into a novel genotype. However, 20% of patients did not fit into autosomal recessive genotype. Current data may suggest the potential contribution of another factor in the pathogenesis of Cystinuria.
Source of Funding: None
MP24-09 THE UPPER AND LOWER TRACT URINARY MICROBIOMES OF STONE FORMERS ARE SIMILAR: A PILOT STUDY
Heiko Yang*, Manint Usawachintachit, Douglas Fadrosh, Susan Lynch, Thomas Chi, San Francisco, CA INTRODUCTION AND OBJECTIVES: Communities of microorganisms that inhabit the human body and are important regulators of the immune system and metabolism are known as a microbiome. The urinary microbiome has been difficult to study due to low bacterial burden and invasiveness of sampling, particularly in the upper tract. It thus remains unclear how it contributes to homeostasis or disease. In this study, we utilize 16S sequencing confirm and characterize the existence of a microbiome in both the upper and lower urinary tract in patients with nephrolithiasis.
METHODS: During endoscopic procedures (5 ureteroscopic, 1 percutaneous nephrolithotomy) for stone removal, we collected specimens from both upper and lower urinary tracts (bladder urine, kidney urine, brush and cup biopsies of renal papilla, and stone fragments) for microbiome analysis. Patients with any history of antibiotic or steroid exposure within six months preceding surgery were excluded. After DNA extraction and PCR amplification, microbiome identification was expressed in operation taxonomic units (OTUs) using 16S ribosomal RNA sequencing from Illumina NextSeq (Illumina, Inc., CA) targeted at the V4 hypervariable region. Paired sequencing reads were quality filtered and demultiplexed using the USEARCH and QIIME software packages before being assembled and further processed. Assembled sequencing read pairs were binned into OTUs using a 97% sequence similarity to a database of known sequences.
RESULTS: Six adult patients with mean age 55.8AE14.4 years and BMI of 29.3AE3.6 kg/m2 undergoing endoscopic stone surgery at our institution were enrolled. Thirty of 33 specimens demonstrated DNA quality above threshold for analysis. A microbiome consisting primarily of proteobacteria, firmicutes, bacteroides, and actinobacteria was demonstrated in both upper and lower urinary tract of the affected kidney in each nephrolithiasis patient. Diversity indices were not significantly different between the upper tract specimens and bladder urine. Two patients with uric acid stones demonstrated enrichment of proteobacteria in their stone specimens which was not observed in the other specimens from these two patients.
CONCLUSIONS: This study confirms the presence of microbial communities in both upper and lower urinary tracts of nephrolithiasis patients with no significant differences between the two. Here we establish a reliable methodology to perform microbiome analysis on the entire urinary tract. Larger scale studies are ongoing to validate these findings and verify how the microbiome plays a role in stone formation and urinary tract infection. 
MP24-10 WAVELENGTH AND PULSE SHAPE EFFECTS ON STONE FRAGMENTATION OF LASER LITHOTRIPTERS
Andreas Gross*, Benedikt Becker, Hamburg, Germany; Mark Taratkin, Dmitry Enikeev, Leonid Rapoport, Moscow, Russian Federation; Christopher Netsch, Hamburg, Germany INTRODUCTION AND OBJECTIVES: Pulsed Holmium:YAG lasers are the energy source of choice in the endoscopic management of urolithiasis. Until recently, pulse frequency and pulse energy were the most investigated parameters to improve efficiency of such lasers. Newer research focusses on the influence of pulse width and pulse shape. Aim of our study was to compare the efficiency of stone dusting of pulsed 2.1mm Holmium:YAG lasers and a pulsed 1.94mm Thuliumfiber laser (TFL) using identical pulse energy, pulse frequency, and average power settings.
METHODS: The lasers systems tested were the Lumenis Versa Pulse Power Suite P 100 (Ho short pulse), the Lumenis Pulse 120H (Ho long pulse) and a commercially not available prototype of a pulsed TFL (Fig.1, A) to C) ). The lasers were tested at 0.2 J and 40 Hz (average power of 8-W). Pulse energies and pulse shapes were measured. Subsequently, efficiency of stone ablation (ablation speed) was compared in vitro on human COM, COM-phosphate, and Uric Acid stones for the three lasers. The in vitro experimental setup included a specially designed cuvette with several levels of metallic meshes allowing for precise quantification of size distribution of stone fragments.
RESULTS: The pulsewidths (range in ms) of all three lasers are shown in Fig. 1 below. The following values of the peak power were derived from the pulse shape and pulse energy measurements: P100: 1650-W, P120: 1040-W, TFL: 660-W. The measured values of stone ablation speed (in dusting mode, i.e. fragments < 1mm) are summarized in Fig.2 .
CONCLUSIONS: The new pulsed TFL shows a clearly defined pulsewidth with a large area under the curve. This in combination with the wavelength superior in terms of water absorption leads to better efficiency of stone fragmentation in dusting mode.
